Centene is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings drop.

Centene’s stock suffers a historic plunge as underestimation of healthcare costs leads the insurer to withdraw its full-year ...

Centene's 40% drop offers a buying opportunity as valuation becomes attractive. Read why I think CNC stock is now ...

Today, some of the biggest losers in the market were a handful of managed care companies led by a company called Centene… ...

UnitedHealth, Centene, and Elevance suffered steep market cap losses amid earnings guidance withdrawals and potential Medicaid changes tied to new legislation.

The 25% decline in Centene’s stock seems warranted given the substantial earnings adjustment and ongoing ambiguity. With more state data still forthcoming and the threat of additional earnings ...

Shares of managed care provider Centene Corp. (NYSE: CNC) dropped over 40% on Wednesday, marking the worst single-day ...

Centene pulled guidance for FY 2025 and indicated that significant cost increases are on the horizon. See why I'm downgrading ...

Centene shares plummeted Wednesday after the managed-care company withdrew its full-year outlook after receiving new data ...

Centene Corp shares fell 25% in after-market trading on Tuesday after the health insurer withdrew its 2025 earnings guidance ...

Centene Corporation (NYSE: CNC) (Centene, the Company) is withdrawing its previous 2025 GAAP and adjusted diluted earnings per share (EPS) guidance, including the underlying guidance elements.